Home > Resources > Company Profiles > Dionex Corporation

Dionex Corporation (DNEX)

EMAIL
PRINT
SHARE
TEXT SIZE:
SHARE
Send a copy to me

Separate multiple email addresses (max 20) with commas.

0/1500
Dr. Lukas Braunschweiler , CEO/President/Director
Industry: Technology
OPEN
LAST
$
PREV CLOSE
CHANGE
VOLUME


Overview
News
People
Financials

Company Information

Dr. Lukas Braunschweiler, CEO/President/Director

1228 Titan Way

Sunnyvale, CA 94085

US Map it

Phone: (408) 737-0700

Fax: (408) 730-9403

www.dionex.com



Overview

The Company designs, manufactures, markets and services analytical instrumentation and related accessories and chemicals.

Employees

Number of Employees: 1,193
Revenue per Employee: $282,355

Top Executives

Dr. Peter Jochum, Senior VP, Divisional
David Bow, Divisional Vice President
John Plohetski, Vice President, Divisional

Dr. Dietrich Hauffe, Divisional Vice President
David Fairbanks, Vice President, Divisional
Kevin Chance, Executive VP/COO

Craig A. McCollam, CFO/Senior VP, Divisional
Bruce Barton, Senior VP, Divisional
Christopher Pohl, Chief Scientific Officer/Senior VP, Divisional

Board of Directors

Michael W. Pope, Director
A. Blaine Bowman, Director
David L. Anderson, Director

Riccardo Pigliucci, Director
Roderick McGeary, Director

Financials

Quarterly
Annual

Income Statement 08/2008 05/2008 02/2008 11/2007
Sales 32.4 Mil. 33.83 Mil. 31.83 Mil. 26.55 Mil.
Gross Operating Profit 66.32 Mil. 64.52 Mil. 66.2 Mil. 55.88 Mil.
Operating Income before D & A (EBITDA) 20.56 Mil. 20.02 Mil. 22.75 Mil. 18.12 Mil.
Total Income Before Interest Expenses (EBIT) 20.15 Mil. 20.19 Mil. 22.37 Mil. 15.85 Mil.
Total Net Income 14.23 Mil. 13.59 Mil. 14.83 Mil. 10.15 Mil.
Basic EPS, Total 0.78 0.74 0.8 0.54
Diluted EPS, Total 0.76 0.72 0.77 0.53

BALANCE STATEMENT 08/2008 05/2008 02/2008 11/2007
Cash and Equivalents 75.62 Mil. 72.03 Mil. 64.25 Mil. 69.58 Mil.
Total Assets 207.04 Mil. 203.08 Mil. 183.9 Mil. 185.77 Mil.
Total Liabilities 100.77 Mil. 96.27 Mil. 78 Mil. 86.7 Mil.
Total Capitalization 332.14 Mil. 195.83 Mil. 193.1 Mil. 185.25 Mil.

Cash Flow 08/2008 05/2008 02/2008 11/2007
Net Cash From Continuing Operations NA NA NA 13.07 Mil.
Net Cash From Investing Activities NA NA NA -2.43 Mil.
Net Cash From Financing Activities NA NA NA 2.27 Mil.
Net Change in Cash & Cash Equivalents NA NA NA 14.64 Mil.

powered by Interactive Data

Income Statement 2008 2007 2006 2005
Sales 126.76 Mil. 100.47 Mil. 93.34 Mil. 85.75 Mil.
Gross Operating Profit 250.78 Mil. 226.81 Mil. 197.96 Mil. 193.57 Mil.
Operating Income before D & A (EBITDA) 79.29 Mil. 78.55 Mil. 62.32 Mil. 70.68 Mil.
Total Income Before Interest Expenses (EBIT) 78.4 Mil. 71.62 Mil. 58.7 Mil. 66.75 Mil.
Total Net Income 52.8 Mil. 45.32 Mil. 35.69 Mil. 45.49 Mil.
Basic EPS, Total 2.85 2.37 1.78 2.2
Diluted EPS, Total 2.77 2.31 1.74 2.13

BALANCE STATEMENT 2008 2007 2006 2005
Cash and Equivalents 75.62 Mil. 54.94 Mil. 43.52 Mil. 42.68 Mil.
Total Assets 207.04 Mil. 170.78 Mil. 157.43 Mil. 152.08 Mil.
Total Liabilities 100.77 Mil. 77.41 Mil. 59.66 Mil. 50.08 Mil.
Total Capitalization 332.14 Mil. 185.71 Mil. 185.38 Mil. 183.05 Mil.

Cash Flow 2008 2007 2006 2005
Net Cash From Continuing Operations NA 68.51 Mil. 51 Mil. 57.17 Mil.
Net Cash From Investing Activities NA -4.04 Mil. -8.74 Mil. -10.91 Mil.
Net Cash From Financing Activities NA -52.39 Mil. -42.31 Mil. -50 Mil.
Net Change in Cash & Cash Equivalents NA 11.41 Mil. 845 K. -3.99 Mil.

powered by Interactive Data







Related Companies by Market Cap
Company Name
Price
Change
Market Cap
Celera Corporation
1.21 Bil.
Bruker Corporation
1.15 Bil.
Affymetrix, Incorporated
1.46 Bil.
Rofin-Sinar Technologies Inc
1.1 Bil.

Company Profile Change Request

The data provided in our company profiles comes from third party information providers.

Also in Portfolio.com
Most Read
Most Emailed
Recently Commented